Early research (Phase 1)Study completedNCT01302145What this trial is testingDrug to Drug Interaction Study With ASP1941 and MetforminWho this might be right forType 2 Diabetes Mellitus Astellas Pharma Inc 36
Testing effectiveness (Phase 2)Study completedNCT01283945What this trial is testingStudy of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid TumorsWho this might be right forSolid Tumors Institut de Recherches Internationales Servier 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730281What this trial is testingPRA-216 COPD Safety and Biomarker StudyWho this might be right forChronic Obstructive Pulmonary Disease (COPD) Prana Therapies Inc 40
Early research (Phase 1)Study completedNCT02808793What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Who this might be right forIndolent Systemic Mastocytosis Allakos Inc. 25
Testing effectiveness (Phase 2)Study completedNCT05479981What this trial is testingExtension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) PatientsWho this might be right forDM1Muscular DystrophiesMyotonic Dystrophy+10 more Avidity Biosciences, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT02476019What this trial is testingA Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese PatientsWho this might be right forObesity Ionis Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT00275093What this trial is testingTemsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver FunctionWho this might be right forHepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 130
Early research (Phase 1)Looking for participantsNCT06299839What this trial is testingPAS-004 in Patients With Advanced Solid TumorsWho this might be right forRAS MutationNF1 MutationRAF Mutation+1 more Pasithea Therapeutics Corp. 48
Early research (Phase 1)Study completedNCT02801981What this trial is testingDose-escalation Study of GSK2330672 in Japanese Healthy Male VolunteersWho this might be right forCholestasis GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT01687309What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 19
Early research (Phase 1)Study completedNCT03918967What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human ParticipantsWho this might be right forHealthy Celltrion 72
Early research (Phase 1)Study completedNCT01606371What this trial is testingA First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT01708564What this trial is testingA Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or BWho this might be right forHemophilia rEVO Biologics 15
Early research (Phase 1)Study completedNCT03430232What this trial is testingFirst-In-Human PainCart Study for STR-324Who this might be right forPain Stragen France 78
Early research (Phase 1)Study completedNCT04006301What this trial is testingFirst-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationWho this might be right forNeoplasmsAdvanced Solid TumorsNon-small Cell Lung Cancer+1 more Janssen Research & Development, LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT05397171What this trial is testingA First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursWho this might be right forUrinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung AstraZeneca 17
Early research (Phase 1)Study completedNCT01862939What this trial is testingA Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Daiichi Sankyo 52
Early research (Phase 1)Study completedNCT01840501What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male ParticipantsWho this might be right forHealthy Janssen Research & Development, LLC 108
Testing effectiveness (Phase 2)Looking for participantsNCT07085507What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS PatientsWho this might be right forMultiple Sclerosis Vidya Therapeutics Inc 100
Testing effectiveness (Phase 2)Ended earlyNCT03573544What this trial is testingThis Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.Who this might be right forMetastatic Solid TumorsLocally Advanced Solid Tumors OBI Pharma, Inc 54